Revenues rose 24.0% year/year to EUR1.46 billion versus the EUR1.4 bln consensus.
For its fourth quarter, the company expects to see revenue of EUR1.1 billion versus the EUR1.14 billion Capital IQ Consensus Estimate. In fiscal year 2011, the company sees revenue of EUR5.5 billion versus the EUR5.54 billion Capital IQ Consensus Estimate.
Additionally, co reports Q3 bookings (excluding EUV) came in just above guidance at EUR514 million. The company sees fourth quarter bookings expected at a level above third quarter. Also sees sales (excluding EUV) to have a gross margin in the fourth quarter 2011 of about 42% (about 41% for sales including EUV). R&D costs for the fourth quarter are expected at EUR150 mln to support our strategic investments. SG&A costs are expected at EUR56 million.






